Evidence map›Paper›PMID 37521700›Full record

ArticleFrontiers in neuroscience2023

EEG response of dexmedetomidine during drug induced sleep endoscopy.

Lichy Han, David R Drover, Marianne C Chen, Amit R Saxena, Sarah L Eagleman, Vladimir Nekhendzy, Angelica Pritchard, Robson Capasso

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lichy HanDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, United States.
David R DroverDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, United States.
Marianne C ChenDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, United States.
Amit R SaxenaDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, United States.
Sarah L EaglemanDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA, United States.
Vladimir NekhendzyDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, United States.
Angelica PritchardDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, United States.
Robson CapassoDepartment of Otolaryngology, Head and Neck Surgery, Stanford University, Stanford, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Dexmedetomidine is one of the anesthetics of choice for drug induced sleep endoscopy (DISE), with advantages including limited respiratory depression, analgesia, and decreased incidence of emergence delirium. However, challenges with determining sedation levels and prolonged recovery have limited its usage. An improved understanding of the effect of dexmedetomidine on the level of sedation and the corresponding electroencephalographic (EEG) changes could help overcome these barriers. Methods: Fifty-one patients received dexmedetomidine sedation with Richmond Agitation-Sedation Scale (RASS) score assessment and continuous EEG monitoring via SedLine for DISE. We constructed a pharmacokinetic model to determine continuous dexmedetomidine blood concentration. From the SedLine, we extracted the patient state index (PSI), and from the EEG we calculated the spectral edge frequency 95% (SEF95) and the correlation dimension (CD), a type of fractal dimension used to assess the complexity of a system. These metrics were subsequently compared against one another and with the dexmedetomidine concentration. Results: Our pharmacokinetic model yielded a two-compartment model with volumes of 51.8 L and 106.2 L, with clearances of 69.5 and 168.9 L/h, respectively, and a time to effect of 9 min, similar to prior studies. Based on this model, decreasing RASS score, SEF95, CD, and PSI were all significantly associated with increasing dexmedetomidine concentration ( Conclusion: Dexmedetomidine use for DISE confirmed previous pharmacokinetic models seen with dexmedetomidine. Complex EEG metrics such as PSI and CD, as compared to RASS score and SEF95, better captured changes in brain state from dexmedetomidine and have potential to improve the monitoring of dexmedetomidine sedation.

Indexed as

dexmedetomidinedrug induced sleep endoscopyelectroencephalographylevel of sedationpharmacology

Identifiers

PMID37521700
PMCPMC10375416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.